Receipt of human papillomavirus vaccine among privately insured adult women in a U.S. Midwestern Health Maintenance Organization

Preventive Medicine

Volumn 57, Issue 5, 2013, Pages 712-714

  Kharbanda, Elyse Olshen ^a   Parker, Emily ^a   Nordin, James D ^a   Hedblom, Brita ^a   Rolnick, Sharon J ^a  

^a HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

Human papilomavirus; Immunization; Women's health

Indexed keywords

WART VIRUS VACCINE;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; ASIAN; BILLING AND CLAIMS; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTRONIC MEDICAL RECORD; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE PLANNING; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE; RECALL; SELF REPORT; TREATMENT OUTCOME; VACCINATION; WOMEN'S HEALTH;

HUMAN PAPILOMAVIRUS; IMMUNIZATION; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ASIAN AMERICANS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION, SECONDARY; INSURANCE COVERAGE; MIDWESTERN UNITED STATES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; YOUNG ADULT;

EID: 84885854713     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.07.011     Document Type: Article

References (20)

1. Anon. Committee opinion no. 467: human papillomavirus vaccination. Obstet. Gynecol. 2010, 116:800-803.
2. Anon. Adult vaccination coverage - United States, 2010. MMWR Morb. Mortal. Wkly Rep. 2012, 61:66-72.
3. Anon. Minnesota Cancer Surveillance System. Cancer in Minnesota, 1988-2009 2012, Minnesota Department of Health, St Paul, MN.
4. Anon. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. MMWR Morb. Mortal. Wkly Rep. 2012, 61:671-677.
5. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am. J. Epidemiol. 2010, 171:357-367.
6. Dempsey A., Cohn L., Dalton V., Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26year old women. Vaccine 2011, 29:528-534.
7. Gordis L. Epidemiology 2004, Elsevier Saunders, Philadelphia, PA. Third ed.
8. Hirth J.M., Tan A., Wilkinson G.S., Berenson A.B. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer 2012, 118(22):5623-5629.
9. Kharbanda E.O., Parker E.D., Nordin J.D., Hedblom B.D., Rolnick S.J. Influenza and Pertussis Vaccination Coverage Among Privately Insured Women of Reproductive Age. Matern. Child Health J. 2013, http://www.ncbi.nlm.nih.gov/pubmed/23108738 (in press) (Electronic publication ahead of print).
10. Laz T.H., Rahman M., Berenson A.B. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 2013, 119:1386-1392.
11. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2007, 56:1-24.
12. Niccolai L.M., Mehta N.R., Hadler J.L. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am. J. Prev. Med. 2011, 41:428-433.
13. Perkins R.B., Brogly S.B., Adams W.G., Freund K.M. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J. Womens Health (Larchmt) 2012, 21:813-820.
14. Polonijo A.N., Carpiano R.M. Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc. Sci. Med. 2013, 82:115-125.
15. Pourat N., Jones J.M. Role of insurance, income, and affordability in human papillomavirus vaccination. Am. J. Manag. Care 2012, 18:320-330.
16. Saraiya M., Ahmed F., Krishnan S., Richards T.B., Unger E.R., Lawson H.W. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet. Gynecol. 2007, 109:360-370.
17. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., Goldie S.J., Harper D.M., Kinney W., Moscicki A.B., Noller K.L., Wheeler C.M., Ades T., Andrews K.S., Doroshenk M.K., Kahn K.G., Schmidt C., Shafey O., Smith R.A., Partridge E.E., Garcia F. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J. Clin. 2007, 57:7-28.
18. Stupiansky N.W., Zimet G.D., Cummings T., Fortenberry J.D., Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J. Adolesc. Health 2012, 50:103-105.
19. Wei F., Moore P.C., Green A.L. Geographic variability in human papillomavirus vaccination among U.S. young women. Am. J. Prev. Med. 2013, 44:154-157.
20. Widdice L.E., Bernstein D.I., Leonard A.C., Marsolo K.A., Kahn J.A. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011, 127:77-84.